Recap: Enanta Pharma Q4 Earnings

Enanta Pharma ENTA reported its Q4 earnings results on Monday, November 20, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Enanta Pharma beat estimated earnings by 33.5%, reporting an EPS of $-1.33 versus an estimate of $-2.0.

Revenue was down $1.39 million from the same period last year.

Last quarter the company beat on EPS by $0.47 which was followed by a 4.24% drop in the share price the next day.

Here's a look at Enanta Pharma's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-2.33	-1.98	-1.59	-1.35
EPS Actual	-1.86	-1.79	-1.39	-1.27
Revenue Estimate	18.06M	19.18M	22.57M	22.86M
Revenue Actual	18.89M	17.80M	23.59M	20.32M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar